Red-light in myopia: Eyecare professionals invited to real-world experiences webinar
Following the recent reclassification of repeated low-level red-light (RLRL) therapy in China, Eyerising International is hosting an online CPD event...
Following the recent reclassification of repeated low-level red-light (RLRL) therapy in China, Eyerising International is hosting an online CPD event...
A gene therapy developed by scientists in the UK has been granted orphan drug designation by the US FDA and...
The Federal Government is deferring the controversial private health insurance reclassification of intravitreal injections for another 12 months and will...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited